Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : THE WHITE HOUSE -- Ignore unavailable to you. Want to Upgrade?

To: MJ who wrote (10802)	11/14/2007 1:19:42 PM
From: DuckTapeSunroof	Respond to of 25737

Re: "It's not a benefit if you get a medicine that is not what it is said to be...." That goes for anything, of course. (The one of the basic jobs of government is to establish systems to verify the safety of goods in international trade.) Other countries with solid health care / pharma distribution systems (UK, Canada, Australia, the E.U., Japan, etc.) haven't had much difficulty establishing procedures to guarantee safety of the pharma they trade amongst themselves --- having their distributors vetted and subject to reciprocal inspections, having their equivalents of FDA and Customs establish required procedures, licensing, and inspection terms... having manufacturers signed up so product is verified from manufacture to retail distribution, etc. No doubt we would not have much difficulty either, were we to go for free - not protected - markets.